scispace - formally typeset
Open AccessJournal ArticleDOI

Advances in RSV vaccine research and development – A global agenda

Deborah Higgins, +2 more
- 03 Jun 2016 - 
- Vol. 34, Iss: 26, pp 2870-2875
Reads0
Chats0
TLDR
This review summarizes current RSV vaccine research and development, including an overview of the vaccine platforms being used, the development stage of individual vaccine candidates, and gaps to be addressed to facilitate use of these vaccines to meet global health needs.
About
This article is published in Vaccine.The article was published on 2016-06-03 and is currently open access. It has received 182 citations till now. The article focuses on the topics: Palivizumab.

read more

Citations
More filters
Journal ArticleDOI

Early-Life Origins of Chronic Obstructive Pulmonary Disease

TL;DR: The effect of early-life exposures on the lung that could lead to expiratory airflow limitation is reviewed.
Journal ArticleDOI

Immunosenescence and human vaccine immune responses.

TL;DR: The functional changes that are known to occur in the adaptive immune system with age are highlighted, followed by a discussion of current, clinically relevant pathogens that disproportionately affect older adults and are the central focus of vaccine research efforts for the aging population.
Journal ArticleDOI

Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055

TL;DR: It is demonstrated that LG2055 has prophylactic potential against RSV infection and the downregulation of SRCAP induced byLG2055 could provide new insights about the inhibition of RSV replication.
Journal ArticleDOI

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

TL;DR: Management of RSV remains centered around prophylaxis with the monoclonal antibody palivizumab, which has proven effective in reducing RSV hospitalization in preterm infants, children with bronchopulmonary dysplasia, and infants with hemodynamically significant congenital heart disease.
Journal ArticleDOI

Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection.

TL;DR: Recent literature exploring genetic and molecular aspects related to RSV infection, their impact on the clinical course of the disease and their potential utility in the development of safe and effective preventive and therapeutic strategies are summarized.
References
More filters
Journal ArticleDOI

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano, +195 more
- 15 Dec 2012 - 
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex, using the Cause of Death Ensemble model.
Journal ArticleDOI

The burden of respiratory syncytial virus infection in young children.

TL;DR: RSV infection is associated with substantial morbidity in U.S. children in both inpatient and outpatient settings, suggesting that control strategies targeting only high-risk children will have a limited effect on the total disease burden of RSV infection.
Journal ArticleDOI

Respiratory syncytial virus infection in elderly and high-risk adults.

TL;DR: In this article, the authors evaluated all respiratory illnesses in prospective cohorts of healthy elderly patients (> or =65 years of age) and high-risk adults (those with chronic heart or lung disease) and in patients hospitalized with acute cardiopulmonary conditions.
Related Papers (5)

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

Ting Shi, +138 more
- 02 Sep 2017 -